PTCE Exam Dumps - PTCB CPhT Questions and Answers

Amlodipine(10 mg) anddiltiazem(30 mg) are bothcalcium channel blockers (CCBs)used to treat hypertension and angina.

When a patient is prescribed two medications from the same therapeutic class, the pharmacy's prescription processing system may flag this as"therapeutic duplication."

This alert is meant toprevent potential adverse effectssuch as excessive lowering of blood pressure or heart rate.

A. Prior authorization required→ Not applicable unless the insurance requires special approval before covering the drug.

C. NDC not covered→ Would appear if the specific drug product (based on its National Drug Code) is not covered by insurance, but this scenario relates to duplication, not coverage.

D. Refill too soon→ This applies to refilling a medication before the allowed time frame, but the scenario describes a new prescription.

PTCB PTCE Exam Content Outline – Drug Interactions and Therapeutic Duplication

Lexicomp and Micromedex Drug Databases– Reference sources for drug classifications.

ISMP Guidelines on Preventing Therapeutic Duplication Errors

Why Other Answers Are Incorrect?Pharmacy Technician References:

Methotrexateis achemotherapy agentand animmunosuppressantused for cancer and autoimmune diseases.

It is classified ashazardous pharmaceutical wasteunderResource Conservation and Recovery Act (RCRA)due to itstoxicity.

It must be disposed of followingEPA guidelines for hazardous waste disposal.

????Reference:RCRA hazardous waste disposal regulations;USP <800> guidelines for hazardous drugs.

Comprehensive and Detailed Step-by-Step Explanation:

Anear miss(also called aclose call) occurs whenan error is detected and corrected before it reaches the patient.Since the incorrect strength was caught before dispensing, this is classified as a near miss.

????Explanation of Answer Choices:✅A. Near miss→Correct.The error wasidentified before reaching the patient, preventing harm.❌B. Adverse drug reaction→ Incorrect.An ADR occurs when a patient experiences an unintended effect from a properly administered drug.❌C. Drug allergy→ Incorrect.An allergic reaction involves the immune system (e.g., rash, anaphylaxis), not a dispensing mistake.❌D. Sentinel event→ Incorrect.Sentinel events involve severe patient harm or death (e.g., wrong drug leading to death).

????Reference:

ISMP Guidelines on Error Reporting

PTCB Exam: Medication Safety & Risk Management

Oxaprozinis anonsteroidal anti-inflammatory drug (NSAID)used to treat arthritis. It is listed on theISMP (Institute for Safe Medication Practices) List of Confused Drug Namesdue to its similarity toTopamax (topiramate), an anticonvulsant used for epilepsy and migraine prevention. The confusion arises because both drug nameslook and sound similar, which can lead to dispensing errors.

A. Tobradex→ Incorrect. Tobradex is anantibiotic/steroid ophthalmic medicationand is not confused with oxaprozin.

C. Tradjenta→ Incorrect. Tradjenta (linagliptin) is aDPP-4 inhibitor for diabetesand is not commonly confused with oxaprozin.

D. Trileptal→ Incorrect. Trileptal (oxcarbazepine) is ananticonvulsantbut is not on the ISMP Confused Drug List with oxaprozin.

Incorrect Answer Choices:Pharmacy Technician References:

PTCB PTCE Exam Content Outline (Error Prevention and Look-Alike/Sound-Alike (LASA) Drugs)

Institute for Safe Medication Practices (ISMP) List of Confused Drug Names

FDA Drug Safety Communications

Mosby’s Pharmacy Technician Exam Review

The CDC emphasizes that handwashing prevents illness primarily because germs (pathogens) are commonly spread when people touch contaminated surfaces, objects, or other people and then touch their eyes, nose, or mouth. Proper handwashing removes these pathogens and interrupts this transmission route. The other options are incorrect: (B) is not a reason recognized by CDC; (C) misstates the mechanism (pathogens on hands don’t “weaken the immune system” directly—transmission to entry sites causes infection); and (D) is false—soap and water are often preferred, and alcohol-based sanitizer does not work against all organisms (e.g., spores like C. difficile and some viruses), whereas handwashing does.

References (Pharmacy Technician documents/Study Guides):

• CDC Hand Hygiene guidance for the public and healthcare settings highlighting touch as a primary transmission pathway and the effectiveness of handwashing.

• PTCB/ExCPT study materials on infection control and hand hygiene principles in pharmacy practice.

• USP <795>/<797> introductory hygiene expectations reinforcing handwashing to reduce contamination risk.

Cefdinir is a third-generation cephalosporin antibiotic commonly used to treat bacterial infections, including otitis media (middle ear infection) in children. It is available in both capsule and suspension forms. However, cefdinir suspension is supplied in different concentrations, typically125 mg/5 mLand250 mg/5 mL.

The prescription provided specifies"Cefdinir suspension 5 mL PO q12h x 10 days", but it does not mention the concentration (strength) of the suspension. Without this crucial information, the pharmacy cannot accurately determine the total dosage the patient will receive. Different strengths would result in significantly different amounts of cefdinir per dose.

For example:

If the prescriber intended125 mg/5 mL, then the patient would receive125 mg per dose (250 mg daily).

If the prescriber intended250 mg/5 mL, then the patient would receive250 mg per dose (500 mg daily).

This discrepancy could lead tounderdosing or overdosing, making it essential for the pharmacy to contact the prescriber to confirm the correct concentration before dispensing.

A. Cefdinir is not available as a suspension.→ Incorrect. Cefdinir is available inoral suspensionform, typically in 125 mg/5 mL and 250 mg/5 mL concentrations.

C. Cefdinir suspension is not indicated for otitis media.→ Incorrect. Cefdinir is FDA-approved for the treatment of otitis media in pediatric patients.

D. Cefdinir suspension was prescribed for a child old enough to swallow capsules.→ Incorrect. While some 8-year-old children may be able to swallow capsules, many pediatric patients prefer liquid formulations, and prescribers often choose suspensions for better compliance.

PTCB PTCE Exam Content Outline – Medication Order Entry and Fill Process(Ensuring accuracy of prescriptions, including strength and formulation).

FDA Drug Label for Cefdinir– Indicates available strengths and dosing requirements.

Lexicomp Drug Information for Cefdinir– Lists the recommended pediatric dosages and available suspension concentrations.

Pharmacology Textbooks (e.g., "Mosby’s Pharmacy Technician: Principles and Practice")– Reinforce the importance of verifying missing prescription details before dispensing.

Why the Other Answer Choices Are Incorrect:Pharmacy Technician References:

AMaster Formulation Record (MFR)is adetailed document used in compounding pharmaciesto ensureconsistency, accuracy, and quality controlin preparing compounded medications.

An MFR includes:

Ingredients & amounts required.

Compounding procedures.

Stability and beyond-use dating (BUD).

Storage and labeling instructions.

This ensures that each compounded preparationmeets quality standardsand ismade correctly every time.

B. Prevent drug diversion❌→Incorrect

Drug diversion prevention involves security measures, inventory control, and trackingcontrolled substances, not MFRs.

C. Eliminate patient profiles❌→Incorrect

Patient profiles are essential for tracking medication history; MFRs are unrelated.

D. Guarantee drug availability❌→Incorrect

MFRs do not affect drug supply; they ensure accurate compounding.

USP <795> (Non-Sterile Compounding Guidelines)– RequiresMaster Formulation Records for all compounded preparations.

PTCB PTCE Exam Content Outline– Covers compounding procedures and quality control measures.

Why Not the Other Options?Key References:

Meclizine (Bonine, Dramamine Less Drowsy)is anover-the-counter (OTC) antihistamineused to treatmotion sickness and vertigo. It works by blockinghistamine (H1) receptorsin thevestibular system, reducing nausea and dizziness associated with motion sickness.

B. Olanzapine→ Incorrect; olanzapine is anatypical antipsychoticused forschizophrenia and bipolar disorder, not motion sickness.

C. Promethazine→ Incorrect; promethazine is anantihistaminethat treatsnausea and motion sickness, but it isonly available by prescription (Rx).

D. Scopolamine→ Incorrect; scopolamine is aprescription (Rx) medicationintransdermal patch formused formotion sickness prevention.

Other Answer Choices Explained:References:

FDA Drug Monograph for Meclizine (OTC Drug Labeling)

PTCB PTCE Exam Content Outline (OTC Medications & Indications)

Lexicomp Drug Monographs for Meclizine, Promethazine, and Scopolamine

The Master Formulation Record (MFR) is a standardized document that provides step-by-step instructions on how to compound a specificnonsterile preparation.

It includes:

Active and inactive ingredients

Mixing instructions

Equipment needed

Beyond-use dating (BUD)

Storage requirements

Why Other Options Are Incorrect:

A. Medication Guide?❌Intended for patient information, not compounding.

C. Patient Package Insert?❌Explains medication use but doesn’t contain compounding instructions.

D. Safety Data Sheet (SDS)?❌Contains safety and hazard information, not formulation instructions.

????Reference:USP <795> Nonsterile Compounding Standards, PTCB Compounding Study Guide.

Step 1: Convert pounds to kilograms

1 kg = 2.2 lbs

132 lbs ÷ 2.2 = 60 kg

Step 2: Calculate total dose

5 mg/kg × 60 kg = 300 mg

Thus, the correct answer isC. 660 mg.

????Reference:PTCE Calculation Guide, Pediatric Dosage Calculations.